Carina Schey
Overview
Explore the profile of Carina Schey including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
116
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Diaz-Manera J, Urtizberea J, Schey C, Kole A, von Gallwitz P, Whiting A, et al.
Neuromuscul Disord
. 2023 Jan;
33(2):208-217.
PMID: 36706619
Although mexiletine effectively treats myotonia, supply disruptions affected Europe between 2008-2018. MyoPath was a mixed-methods, cross-sectional, market research survey conducted January-June 2018 to evaluate consequences of limited access to/awareness of...
2.
Schey C, Postma M, Krabbe P, Topachevskyi O, Volovyk A, Connolly M
Front Public Health
. 2020 May;
8:162.
PMID: 32457865
Increasingly, multi-criteria decision analysis has gained importance as a method by which to assess the value of orphan drugs. However, very little attention has been given to the weight (relative...
3.
Schey C, Meier G, Pan J
Adv Ther
. 2019 Apr;
36(6):1266-1278.
PMID: 30953332
Introduction: Metastatic renal cell carcinoma is a complex cancer for which several drugs have been developed over the years. More recently, drugs that target the specific cancer cell mutations have...
4.
Connolly M, Goodwin E, Schey C, Zummo J
Pathog Glob Health
. 2017 Jan;
111(1):31-44.
PMID: 28090819
Toxoplasmic encephalitis (TE) is caused by Toxoplasma gondii infection and can be a life-threatening disease in immunocompromised patients. This study evaluated the rate of relapse associated with pyrimethamine-based maintenance therapy...
5.
Hutchings A, Schey C, Dutton R, Achana F, Antonov K
Orphanet J Rare Dis
. 2014 Feb;
9:22.
PMID: 24524281
Background: The growth in expenditure on orphan medicinal products (OMP) across Europe has been identified as a concern. Estimates of future expenditure in Europe have suggested that OMPs could account...
6.
Oliva E, Schey C, Hutchings A
Am J Blood Res
. 2012 Mar;
1(2):160-6.
PMID: 22432077
Background: Anemia is an important cause of morbidity in MDS patients, principally through increased cardiovascular disease. Transfusion status has been seen to be a significant prognostic factor for disease progression...
7.
Schey C, Milanova T, Hutchings A
Orphanet J Rare Dis
. 2011 Sep;
6:62.
PMID: 21951518
Background: Orphan drugs are a growing issue of importance to European healthcare policy makers. The success of orphan drug legislation in Europe has resulted in an increasing number of licensed...